Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer
- 1 February 2001
- Vol. 57 (2) , 281-285
- https://doi.org/10.1016/s0090-4295(00)00914-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Neoadjuvant Chemotherapy and Hormonal Therapy Followed by Radical Prostatectomy: Feasibility and Preliminary ResultsJournal of Clinical Oncology, 2000
- Acute Complications after Radical Retropubic ProstatectomyThe Prostate Journal, 2000
- Contemporary results of anatomic radical prostatectomy.CA: A Cancer Journal for Clinicians, 1999
- CANCER RECURRENCE AND SURVIVAL RATES AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCERJournal of Urology, 1998
- Initial Dissection of the Lateral Fascia Reduces the Positive Margin Rate in Radical ProstatectomyUrology, 1998
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997
- PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 1997
- Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancerUrology, 1996
- IS "OFF-PROTOCOL" CHEMOTHERAPY FOR ANDROGEN-INDEPENDENT CARCINOMA OF PROSTATE WARRANTEDHematology/Oncology Clinics of North America, 1996
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate CancerJournal of Urology, 1995